ARCHIVES

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

This article is from The Cancer Letter archive.

Vol. 35 No. 34 | September 18, 2009

Download PDF Visit The Full Archive

Related Articles

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

AACI Resolution Asks Congress To Support 1991 Bypass Budget

July 13, 1990

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991

Myriad In Partnership To Market Products.

December 14, 2001